Master's degree in pharmaceutical biotechnology
The work developed by a student during one academic year, according to the indicative plan of the course and on a full time basis, totals 60 ECTS.
Study Programme
| Option Rule | Course unit title | Year | Regime | Type | Subject area | ECTS credits |
|---|---|---|---|---|---|
| Industrial Production of Biotechnological Products | 1 | 1st Semester | Compulsory | CF | 6.0 |
| Molecular Mechanisms of the Diseases and Biological Models | 1 | 1st Semester | Compulsory | CBB | 6.0 |
| Nanotechnology | 1 | 1st Semester | Compulsory | CF | 6.0 |
| Recombinant DNA Technology | 1 | 1st Semester | Compulsory | CTS | 6.0 |
| Biopharmaceuticals in Clinical Practice | 1 | 2nd Semester | Compulsory | CTS | 6.0 |
| Molecular Diagnosis | 1 | 2nd Semester | Compulsory | CTS | 6.0 |
| Molecular Therapeutics and Tissue Engineering | 1 | 2nd Semester | Compulsory | CTS | 6.0 |
| Pharmacogemonics and Risk Management | 1 | 2nd Semester | Compulsory | CTS | 6.0 |
| Project: Research, Valuation and Entrepreneurship | 1 | Semestrial | Elective * | EO | 6.0 |
| Scientific and Entrepreneurial Solutions for Biotechnology in Portugal | 1 | Semestrial | Elective * | EO | 6.0 | Course unit title | Year | Regime | Type | Subject area | ECTS credits |
| Thesis/Project | 2 | Annual | Compulsory | CTS | 60.0 |
The optional course units are offered on a yearly basis, depending on the availability of the Organic Unit